Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 2
2003 1
2004 3
2005 2
2006 6
2007 8
2008 12
2009 7
2010 4
2011 11
2012 10
2013 7
2014 3
2015 7
2016 3
2017 9
2018 8
2019 7
2020 10
2021 8
2022 11
2023 11
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

134 results

Results by year

Filters applied: . Clear all
Page 1
Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) in 2023.
Cohen Tervaert JW, Martinez-Lavin M, Jara LJ, Halpert G, Watad A, Amital H, Shoenfeld Y. Cohen Tervaert JW, et al. Autoimmun Rev. 2023 May;22(5):103287. doi: 10.1016/j.autrev.2023.103287. Epub 2023 Feb 3. Autoimmun Rev. 2023. PMID: 36738954 Free article. Review.
Breast implant illness: scientific evidence of its existence.
Cohen Tervaert JW, Mohazab N, Redmond D, van Eeden C, Osman M. Cohen Tervaert JW, et al. Expert Rev Clin Immunol. 2022 Jan;18(1):15-29. doi: 10.1080/1744666X.2022.2010546. Epub 2022 Jan 5. Expert Rev Clin Immunol. 2022. PMID: 34882509 Review.
These symptoms received different names such as autoimmune/autoinflammatory syndrome induced by adjuvants (ASIA) due to silicone incompatibility syndrome and breast implant illness (BII). ...
These symptoms received different names such as autoimmune/autoinflammatory syndrome induced by adjuvants (ASIA) due to silico …
Vaccination and Induction of Autoimmune Diseases.
Toussirot É, Bereau M. Toussirot É, et al. Inflamm Allergy Drug Targets. 2015;14(2):94-8. doi: 10.2174/1871528114666160105113046. Inflamm Allergy Drug Targets. 2015. PMID: 26728772 Review.
The role of adjuvants in vaccines has been described by other teams and in a more general syndrome (Autoimmune/Autoinflammatory Syndrome Induced by Adjuvants). Thus, cases of AID triggered by vaccines are highly rare and raise questions about the interaction between …
The role of adjuvants in vaccines has been described by other teams and in a more general syndrome (Autoimmune/Autoinflammatory Sy …
Cold urticaria - What we know and what we do not know.
Maltseva N, Borzova E, Fomina D, Bizjak M, Terhorst-Molawi D, Košnik M, Kulthanan K, Meshkova R, Thomsen SF, Maurer M; COLD-CE Steering Committee. Maltseva N, et al. Allergy. 2021 Apr;76(4):1077-1094. doi: 10.1111/all.14674. Epub 2020 Dec 24. Allergy. 2021. PMID: 33249577 Review.
Here, we review what is known about ColdU, and we present important unanswered questions on the epidemiology, underlying pathomechanisms, clinical heterogeneity and treatment outcomes. Our aim is to guide future efforts that will close these knowledge gaps and advance the …
Here, we review what is known about ColdU, and we present important unanswered questions on the epidemiology, underlying pathomechanisms, …
Distinct interferon signatures and cytokine patterns define additional systemic autoinflammatory diseases.
de Jesus AA, Hou Y, Brooks S, Malle L, Biancotto A, Huang Y, Calvo KR, Marrero B, Moir S, Oler AJ, Deng Z, Montealegre Sanchez GA, Ahmed A, Allenspach E, Arabshahi B, Behrens E, Benseler S, Bezrodnik L, Bout-Tabaku S, Brescia AC, Brown D, Burnham JM, Caldirola MS, Carrasco R, Chan AY, Cimaz R, Dancey P, Dare J, DeGuzman M, Dimitriades V, Ferguson I, Ferguson P, Finn L, Gattorno M, Grom AA, Hanson EP, Hashkes PJ, Hedrich CM, Herzog R, Horneff G, Jerath R, Kessler E, Kim H, Kingsbury DJ, Laxer RM, Lee PY, Lee-Kirsch MA, Lewandowski L, Li S, Lilleby V, Mammadova V, Moorthy LN, Nasrullayeva G, O'Neil KM, Onel K, Ozen S, Pan N, Pillet P, Piotto DG, Punaro MG, Reiff A, Reinhardt A, Rider LG, Rivas-Chacon R, Ronis T, Rösen-Wolff A, Roth J, Ruth NM, Rygg M, Schmeling H, Schulert G, Scott C, Seminario G, Shulman A, Sivaraman V, Son MB, Stepanovskiy Y, Stringer E, Taber S, Terreri MT, Tifft C, Torgerson T, Tosi L, Van Royen-Kerkhof A, Wampler Muskardin T, Canna SW, Goldbach-Mansky R. de Jesus AA, et al. J Clin Invest. 2020 Apr 1;130(4):1669-1682. doi: 10.1172/JCI129301. J Clin Invest. 2020. PMID: 31874111 Free PMC article. Clinical Trial.
Patients with LRBA, IKBKG, and SAMD9L mutations showed a pattern of IRG elevation that suggests prominent NF-kappaB activation different from the canonical interferonopathies CANDLE, SAVI, and AGS.CONCLUSIONSIn patients with elevated IRG-S, we identified characteristic clinica …
Patients with LRBA, IKBKG, and SAMD9L mutations showed a pattern of IRG elevation that suggests prominent NF-kappaB activation different fro …
Complex Autoinflammatory Syndrome Unveils Fundamental Principles of JAK1 Kinase Transcriptional and Biochemical Function.
Gruber CN, Calis JJA, Buta S, Evrony G, Martin JC, Uhl SA, Caron R, Jarchin L, Dunkin D, Phelps R, Webb BD, Saland JM, Merad M, Orange JS, Mace EM, Rosenberg BR, Gelb BD, Bogunovic D. Gruber CN, et al. Immunity. 2020 Sep 15;53(3):672-684.e11. doi: 10.1016/j.immuni.2020.07.006. Epub 2020 Aug 3. Immunity. 2020. PMID: 32750333 Free PMC article.
Given these results, the patient was treated with tofacitinib, a JAK inhibitor, leading to the rapid resolution of clinical disease. These findings offer a platform for personalized medicine with the concurrent discovery of fundamental biological principles....
Given these results, the patient was treated with tofacitinib, a JAK inhibitor, leading to the rapid resolution of clinical disease. …
Dermatology facing autoinflammatory syndrome.
Alecu M, Coman G, Muşetescu A, Cojoacă ME, Coman OA. Alecu M, et al. Rom J Morphol Embryol. 2015;56(1):7-14. Rom J Morphol Embryol. 2015. PMID: 25826481 Free article. Review.
Several skin disorders (pyoderma gangrenosum and pustular acne) may be encountered either isolate or associated with autoinflammatory symptoms, forming well-defined clinical entities within the autoinflammatory syndrome. The high prevalence of cutaneous manif …
Several skin disorders (pyoderma gangrenosum and pustular acne) may be encountered either isolate or associated with autoinflammatory sympto …
Targeting cytokines to treat autoinflammatory diseases.
Hausmann JS. Hausmann JS. Clin Immunol. 2019 Sep;206:23-32. doi: 10.1016/j.clim.2018.10.016. Epub 2018 Oct 28. Clin Immunol. 2019. PMID: 30394352 Review.
In this review, I will discuss the most common autoinflammatory conditions of adulthood including familial Mediterranean fever (FMF), cryopyrin-associated periodic syndrome (CAPS), mevalonate kinase deficiency/hyperimmunoglobulinemia D Syndrome (MKD/HIDS), TNF receptor-associated …
In this review, I will discuss the most common autoinflammatory conditions of adulthood including familial Mediterranean fever (FMF), cryopy …
An Update on the Use of Immunomodulators in Primary Immunodeficiencies.
Vignesh P, Rawat A, Singh S. Vignesh P, et al. Clin Rev Allergy Immunol. 2017 Apr;52(2):287-303. doi: 10.1007/s12016-016-8591-2. Clin Rev Allergy Immunol. 2017. PMID: 27873163 Review.
These agents have been shown conclusively to favorably modulate immune responses, resulting in abatement of clinical manifestations both in experimental models and patients. While some of the treatment options have been approved for therapeutic use or have been shown to be …
These agents have been shown conclusively to favorably modulate immune responses, resulting in abatement of clinical manifestations b …
Similarities and differences in autoinflammatory diseases with urticarial rash, cryopyrin-associated periodic syndrome and Schnitzler syndrome.
Matsuda T, Takimoto-Ito R, Lipsker D, Kambe N. Matsuda T, et al. Allergol Int. 2023 Jul;72(3):385-393. doi: 10.1016/j.alit.2023.02.005. Epub 2023 Mar 10. Allergol Int. 2023. PMID: 36906447 Free article. Review.
With the advent of IL-1-targeted therapies, the prognosis of CAPS has improved remarkably. SchS is considered an acquired form of autoinflammatory syndrome. Patients with SchS are adults of relatively older age. ...If targeted IL-1 treatment does not improve symptom …
With the advent of IL-1-targeted therapies, the prognosis of CAPS has improved remarkably. SchS is considered an acquired form of autoinf …
134 results